1. Home
  2. Analysis
  3. Ceftriaxone
  4. Ileus-paralytic

Ceftriaxone and Ileus paralytic - a phase IV clinical study of FDA data

Summary:

Ileus paralytic is reported as a side effect among people who take Ceftriaxone (ceftriaxone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Methylprednisolone, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Ileus paralytic when taking Ceftriaxone. It is created by eHealthMe based on reports of 40,872 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Ileus paralytic?

Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles) is found to be associated with 683 drugs and 851 conditions by eHealthMe. Check the latest studies of Ileus paralytic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

40,872 people reported to have side effects when taking Ceftriaxone.
Among them, 35 people (0.09%) have Ileus paralytic.

Could Ceftriaxone cause Ileus paralytic?

Among these 35 people:

How long have people been on Ceftriaxone when they have Ileus paralytic? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Ileus paralytic when taking Ceftriaxone? *

  • female: 16.13 %
  • male: 83.87 %

What is the age of people who have Ileus paralytic when taking Ceftriaxone? *

  • 0-1: 0.0 %
  • 2-9: 9.38 %
  • 10-19: 9.38 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.12 %
  • 50-59: 12.5 %
  • 60+: 65.62 %

What are other drugs people take besides Ceftriaxone? *

  1. Vancomycin: 12 people, 34.29%
  2. Methylprednisolone: 12 people, 34.29%
  3. Metronidazole: 7 people, 20.00%
  4. Potassium: 6 people, 17.14%
  5. Prednisone: 6 people, 17.14%
  6. Lantus: 6 people, 17.14%
  7. Novorapid: 6 people, 17.14%
  8. Fluconazole: 6 people, 17.14%
  9. Phenytoin: 6 people, 17.14%
  10. Metformin Hydrochloride: 6 people, 17.14%

What are other side effects people have besides Ileus paralytic? *

  1. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 13 people, 37.14%
  2. Thrombocytopenia (decrease of platelets in blood): 9 people, 25.71%
  3. Diarrhea: 9 people, 25.71%
  4. Hypotension (abnormally low blood pressure): 8 people, 22.86%
  5. Pleural Effusion (water on the lungs): 8 people, 22.86%
  6. Aspartate Aminotransferase Increased: 7 people, 20.00%
  7. Leukocytosis (increased white blood cells): 7 people, 20.00%
  8. Gamma-Glutamyltransferase Increased: 7 people, 20.00%
  9. Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 20.00%
  10. Anaemia (lack of blood): 6 people, 17.14%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 7 people, 20.00%
  2. Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 20.00%
  3. Type 2 Diabetes: 7 people, 20.00%
  4. Dyspnea (difficult or laboured breathing): 6 people, 17.14%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 17.14%
  6. Gamma-Glutamyltransferase Increased: 6 people, 17.14%
  7. Hypokalemia (low potassium): 6 people, 17.14%
  8. Urinary Tract Infection: 2 people, 5.71%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 5.71%
  10. Cardiac Failure: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Ileus paralytic?

- Check whether Ileus paralytic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone:

Ileus paralytic treatments and more:

How severe was Ileus paralytic and when was it recovered:

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ileus paralytic:

Browse all the conditions that are associated with Ileus paralytic:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.